Knee Implants Market Size, Trends 2020 – Global Industry Analysis By Top Leaders, Demand, Technologies, consumables, Size, Investment Share and Country Level Analysis to Forecast by 2026


News provided by

Comserve Inc.

Feb 14, 2020, 06:48 EST


Bronx, United States, Feb 14, 2020, 06:48 /Comserve / -- Coherent Market Insights has recently shared a report on Knee Implants Market Size, Trends 2020, Industry Analysis By Top Leaders, Demand, Technologies, consumables, Size, Investment Share and Country Level Analysis to Forecast by 2026

Image placeholder

Knee implantation or also known as arthroplasty is a surgical procedure to replace the weight-bearing surfaces of the knee joint relieve pain and disability. It is one of the most common surgical procedures performed for osteoarthritis and some other knee diseases such as rheumatoid arthritis and psoriatic arthritis. For keen implant surgery, the implants components are made up of ceramic materials, strong plastic parts or metal alloys.  There are four types of arthroplasty namely kneecap replacement, partial knee replacement, complex knee replacement, and total knee replacement.

Download the Sample copy Of Report with Table of Contents and Figures @ https://www.coherentmarketinsights.com/insight/request-sample/459

Total knee replacement involves the replacement of the surface of the thigh bone and the shin connected to the knee. Partial knee replacement or uni-compartmental knee replacement, can be performed through a small cut were one side of the knee is affected. Different types of fixation are used in knee implantation to connect knee implants to the bone, these include hybrid fixation, cementless fixation and cemented fixation. In cemented fixation, the implants are held in place with a fast curing bone cement such as polymethylmethacrylate. On the contrary, in cementless fixation, the implants are press-fit on to the bone so as to augment new bone growth.

According to the Centers of Medicare and Medicaid Services (CMS) around, 10% of knee replacement surgeries in the U.S. are partial knee replacements. Generally, patients who have undergone the partial knee replacement have osteoarthritis in one compartment of their knee. In kneecap replacement only the under surface of the knee is replaced and it is a small joint replacement procedure.

Furthermore, according to National Joint Registry, around 160,000 knee replacement procedures are performed as well as equal number knee joints are replaced, each year in England and Wales. Also, as per Organization for Economic Co-operation and Development (OECD), in the U.S., 226 per 1000 population knee replacement surgery were performed in 2013.

Global Knee Implants Market Taxonomy:

By Product Type:

  • Total Knee Replacement
  • Partial Knee Replacement
  • Complex Knee Replacement
  • Kneecap Replacement

By Material:

  • Ceramics
  • Stainless Steel
  • Cobalt-Chromium Alloys
  • Polyethylene
  • Titanium Alloys
  • Others

By End User:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers

Market Outlook

Increasing prevalence of arthritis and obesity to support growth of the global knee implants market in the near future

Among regions, North America and Europe account for the major market share in the global knee implantation market. Asia Pacific is expected to witness rapid growth in the global knee implants market, owing to growing population in the age group of 20-65 years, in this region. This growth is supported by development of healthcare infrastructure and increasing availability of healthcare facilities. Growing population and prevalence of bone and joint disorders are also expected to fuel growth of the global knee implant market.

According to Centers for Disease Control and Prevention (CDC), during 2013-2015, around 54.4 million adults in the U.S. (22.7%) yearly suffered from some form of arthritis such as rheumatoid arthritis, gout, lupus, or fibromyalgia. According to the National Center for Biotechnology Information (NCBI), in 2016 the prevalence of knee arthritis in India was found to be around 28.7% in overall population. Furthermore, as per National Center for Health Statistics (NCHS), during 2011–2014, the prevalence of obesity was around 36% in adults and 17% in youth in the U.S.

Growing obese population in emerging economies is expected to boost growth of the knee implantation market. According to World Health Organization (WHO), in 2014, the obese adult population in China was around 6.9% and in India was around 4.9%, and the number is expected to increase rapidly.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/knee-implants-market-459

Competitive Landscape:

Key players operating in the global knee implantation market are Zimmer, Stryker, Smith & Nephew plc, Johnson & Johnson, DJO Global, Inc., Exactech, Inc., Zimmer Biomet Holdings, Inc., B. Braun Melsungen AG, MicroPort Scientific Corporation, DePuy Synthes, and Arthrex.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

sales@coherentmarketinsights.com

U.S. Office:

Name:  Mr. Shah

Coherent Market Insights 1001 4th Ave,

#3200 Seattle, WA 98154, U.S.

US :  +1-206-701-6702

UK :  +44-020-8133-4027

JAPAN :  +050-5539-1737

COMSERVE empowers communicators by offering modern digital PR solutions and distribution services to identify and engage with customers, opinion leaders, bloggers and other relevant audience.


For more information, please contact:

Anna R .Moser

Comserve Inc.
Email: info@comserveonline.com
Tel: 9718945348

Related Links
https://www.comserveonline.com/



Also from this source


Recession hits the UK after 11 years

UK has officially gone into recession with the economy shrinking by 20.4% in the second quarter.


AstraZeneca signs its first deal with Kangtai Bio to supply potential COVID-19 vaccine in China

The British drug-maker, AstraZeneca signed an exclusive deal with Beijing based Shenzhen Kangtai Bio